Sanofi partners with OpenAI, Formation Bio on AI-driven drug development. By Reuters. May 21, 2024 8:28 PM UTC Updated May 21, 2024 The logo of French drugmaker Sanofi is seen a the ...

Sanofi, Formation Bio and OpenAI have jointly designed an AI-powered tool that will be rolled out in the former's phase 3 multiple sclerosis trials. There’s a new Muse in town.

AI-based drug developer Formation Bio said on Wednesday that it has raised $372 million in a late-stage funding round, with a significant participation from French drugmaker Sanofi .